KAYLEE CASPER: Open Payments
NPI 1770172728 · AUBURN, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$342 in 15 payments from 8 companies in 2025. Trend: 2023 $1,433 · 2024 $674 · 2025 $342
Food & beverage: $342
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $151 |
| ABBVIE INC. | 3 | $45 |
| Otsuka America Pharmaceutical, Inc. | 2 | $39 |
| PFIZER INC. | 2 | $36 |
| Corcept Therapeutics | 1 | $20 |
| Exeltis, USA Inc. | 1 | $19 |
| Lundbeck LLC | 1 | $17 |
| AstraZeneca Pharmaceuticals LP | 1 | $15 |
Products named: CAPLYTA, REXULTI, NURTEC ODT, Korlym, SLYND, QULIPTA, BREZTRI, UBRELVY.
Industry payments across IN — which companies pay providers there.
